This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
N. Berhe , S. Gunderson , F. Abebe , H. Birrie , G. Medhin and T. Gemetchu (1999). Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia. Acta Tropica 72, 53–63.
S. Botros , H. Sayed , N. Amer , M. El Ghannam , J. L. Bennett and T. A. Day (2005). Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. International Journal for Parasitology 35, 787–791.
L. Chitsulo , D. Engels , A. Montresor and L. Savioli (2000). The global status of schistosomiasis and its control. Acta Tropica 77, 41–51.
J. A. Clegg (1965). In vitro cultivation of Schistosoma mansoni. Experimental Parasitology 16, 133–147.
A. Danso-Appiah and S. J. De Vlas (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology 18, 125–129.
A. Fenwick , L. Savioli , D. Engels , N. Bergquist and M. Todd (2003). Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology 19, 509–515.
B. Gryseels , A. Mbaye , S. J. De Vlas , F. F. Stelma , F. Guisse , L. Van Lieshout , D. Faye , M. Diop , A. Ly , L. A. Tchuem-Tchuente , D. Engels and K. Polman (2001). Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health 6, 864–873.
B. Gryseels , L. Nkulikyinka and M. H. Coosemans (1987). Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 641–644.
C. King , K. Dickman and D. Tisch (2005). Re-assessment of the cost of chronic helminthic infections: A meta-analysis. The Lancet 365, 1561.
V. Kumar and B. Gryseels (1994). Use of praziquantel against schistosomiasis: a review of the current status. International Journal of Antimicrobial Agents 4, 313–320.
N. Midzi , D. Sangweme , S. Zinyowera , M. P. Mapingure , K. C. Brouwer , N. Kumar , F. Mutapi , G. Woelk and T. Mduzola (2008). Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 759–766.
M. Picquet , J. Vercruysse , D. J. Shaw , M. Diop and A. Ly (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 90–93.
A. M. Polderman , B. Gryseels and P. De Caluwe (1988). Cure rates and egg reduction in treatment of intestinal schistosomiasis with oxamniquine and praziquantel in Maniema, Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 115–116.
G. Raso , E. N'Goran , A. Totay , A. Luginbuhe , C. A. Adjoua , N. T. Tian-Bi , I. I. Bogoch , P. Vounatsou , M. Tanner and J. Utzinger (2004). Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Cote d'Ivoire. Transactions of the Royal Society of Tropical Medicine and Hygiene 98, 18–27.
E. Renganathan and D. Cioli (1998). An international initiative on praziquantel use. Parasitology Today 14, 390–391.
A. A. Sabah , C. Fletcher , G. Webbe and M. Doenhof (1986). Schistosoma mansoni chemotherapy of infections of different ages. Experimental Parasitology 61, 294–303.
J. Utzinger , J. Keiser , X. Shuhua , M. Tanner and B. H. Singer (2003). Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrobial Agents and Chemotherapy 47, 1487–1495.
J. Utzinger , E. N'Goran , A. N'Dri , C. Lengler and M. Tanner (2000). Efficacy of praziquantel against Schistosoma mansoni with particular consideration of intensity of infection. Tropical Medicine and International Health 5, 771–778.
S. H. Xiao , B. A. Catto and L. T. Webester (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases 151, 1130–1137.